Combination chemotherapy with continuous infusion of low-dose cisplatin and UFT for advanced non-small cell lung cancer
Seike, M.; Andoh, M.; Hasegawa, K.; Sakonji, M.; Tsuboi, E.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(10): 1539-1542
1998
ISSN/ISBN: 0385-0684 PMID: 9725046 Document Number: 497220
A combination chemotherapy with continuous infusion of cisplatin (5 mg/body, day 1-5) and UFT (400-600 mg/body, day 1-5) was administered to thirteen patients for advanced non-small cell lung cancer. Myelosuppression and other toxicity were mild, and the quality of life of the patients was good. The response rate of thirteen patients was 23% (CR 0, PR 3). It was considered that chemotherapy using cisplatin (5 mg/body, day 1-5) and UFT (400-600 mg/body, day 1-5) was well tolerated and effective for the treatment of non-small cell lung cancer.